SKU: C123  / 
    CAS Number: 66-81-9

    Cycloheximide A, EvoPure®

    $76.03 - $111.11

    Cycloheximide A, EvoPure® is a highly purified (≥99.0) form of Cycloheximide A, the active compound in standard grade cycloheximide.  Cycloheximide is a glutarimide antibiotic and natural fungicide isolated from Streptomyces griseus and a protein synthesis inhibitor in eukaryotic cells.  It was discovered by Alma Whiffen-Barksdale of Upjohn Company in 1946.  The compound is routinely used as a selection agent in several types of isolation media.  Cycloheximide can be used as a tool in molecular biology for ribosome profiling/translational profilingto understand the complexity of translation initiation. It cna be used to study protein syntheesis, expression and degradation, and determine the half-life of proteins, or in in chase experiments to analyze protein degradation.

    Cycloheximide A, EvoPure® is soluble in DMSO or ethanol.

    This product is considered a dangerous good. Quantities above 1 g may be subject to additional shipping fees. Please contact us for details.

    We also offer:

    • Cycloheximide (C001)
    • Cycloheximide Solution (C084)
    • Cycloheximide, CulturePure® (C071)
    Application Cycloheximide is used in molecular biology for ribosome profiling / translational profiling to understand the complexity of translation initiation. Cycloheximide is used to study protein synthesis, expression and degradation, and determine the half-life of proteins.
    Mechanism of Action Cycloheximide binds to the ribosome and inhibits the eEF2-mediated translocation step in protein synthesis, thus blocking translational elongation.
    Spectrum Cycloheximide is used for fungi and yeast, including fungi found in brewing test media. It has lower activity against bacteria.
    Microbiology Applications Cycloheximide chase followed by western blotting was used to analyze protein degradation in the model unicellular eukaryote, S. cerevisiae (buddiing yeast). Yeast cells are incubated in cycloheximide and cell aliquots are collected after specific time points. This allows visualization of the degradation kinetics of the steady state population of a variety of cellular proteins (Buchanan et al, 2016).

    Representative susceptibility data includes:

    • Candida albicans: 12.5 µg/ml
    • Saccharomyces cerevisiae: 0.2 µg/ml
    • Mycosphaerella graminicola: 5.62-100 µg/ml

     For additional Cycloheximide MIC data, please review our Antimicrobial Index.

    Plant Biology Applications Cycloheximide is a commonly used lab reagent used for in vitro applications to inhibit fungal growth by targeting protein synthesis. In yeast, concentrations of 200 uM have fungicidal effects (Schneider-Poetsch et al, 2009). The compound can be used as a plant growth regulator to stimulate ethylene production in leaves and fruit.
    Eukaryotic Cell Culture Applications Cycloheximide is widely used in biomedical research to inhibit protein synthesis in eukaryotic cells in vitro. It inhibits the synthesis of proteins and macromolecules,and affects apoptosis in eukaryotes.

    Cycloheximide Solution (C084) was used to study transcription factors (LMX1A and LMX1B) in the adult midbrain, contributing to our understanding of dopaminergic neuronal (mDAN) decline in Parkinson’s disease (Jimenez-Moreno et al, 2019).   

    Cancer Applications Pretreatment with Cycloheximide followed by estrogen stimulation prevented the estrogen-induced changes in glucose metabolism in perfused breast cancer T47D clone 11 cells. This suggested that the estrogen stimulation requires synthesis of mRNA and protein (Neeman and Degani, 1989). In studying the “immune escape” of cancer cells, in human colorectal cancer cell line COLO 205 is normally resistant to TNF-alpha - a death inducing ligand. However, co-incubation TNF-alpha with cycloheximide caused time-dependent cell death. In fact, authors found that Cycloheximide sensitizes cells to TNF-alpha-induced apoptosis (Pajak et al, 2005).
    References Baliga BS, Pronczuk AW and Munro HN (1969) Mechanism of cycloheximide inhibition of protein synthesis in a cell-free system prepared from rat liver. J Biol Chem. 244(16):4480-4489 PMID 5806588

    Doyle SM, Diamond M and McCabe PF (2010) Chloroplast and reactive oxygen species involvement in apoptotic-like programmed cell death in Arabidopsis suspension cultures. J. Exper. Bot 61 (2):473–482 PMID 19933317

    Lee S et al (2012) Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc Natl Acad Sci USA. 109(37):E2424-32 PMID 22927429

    Neeman M and Degani H (1989) Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: 31P and 13C NMR studies. PNAS 86 (14):5585-5589 PMID 2748604

    Pajak B, Gajkowska B, Orzechowski A (2005) Cycloheximide-mediated sensitization to TNF-alpha-induced apoptosis in human colorectal cancer cell line COLO 205; role of FLIP and metabolic inhibitors. J. Physiol. Pharmacol.56 (3)101-118. PMID 16077198

    Schneider-Poetsch T et al (2009) Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat. Chem. Biol 6: 209-217 PMID 20118940